Advancements in nanotechnology and clinical developments in dural grafts used for neurosurgical procedures are the key factors driving the growth of the dural graft market. Scientific effectiveness and safety gaps are being bridged by leading industry players.
Clinical efficacy, improved safety, and minimal side-effects are factors leading to rapid adoption of dural grafts, such as synthetic and xenogeneic dural products. For instance, in 2015, a study published in the Journal of American Medical Association found that, between 2006 and 2014, the number of industry-funded clinical trials increased by 43%.
In conclusion, industries are actively engaged in the research & development of novel dural graft products as the primary sponsor for clinical research, which is anticipated to positively impact the dural graft market.
Find Out More about the Report Coverage
- Cook Medical.
- Integra Lifesciences Corporation
- B Braun
- Cousin Biotech,
- Natus Medical Incorporated
- Tissuemed Ltd,
- Vostra GmbH
- Stryker Corporation
- Medtronic Plc.
- Johnson & Johnson,
- Aesculap, Inc.
- Baxter International Inc
Government Initiatives for Innovative Regenerative Medicine Boosting Dural Graft Market Growth
Regenerative medicine has been recognized by governments across various countries. Government support is increasing globally for the treatment of various diseases through the formation and adoption of supportive legislative and policies, which is anticipated to benefit the dural graft market landscape.
This also includes sizeable investments for regenerative therapies to create centers of excellence, research networks, manufacturing infrastructure, and commercialization centers, among others. For example, in 2010, NIH Common Fund launched the NIH Center for Regenerative Medicine, with the goal of serving as a national resource for stem cell science to accelerate the development of new medical applications and cell-based therapies.
Also, the Orthopedic Research and Education Foundation (OREF), in collaboration with the American Orthopedic Society for Sports Medicine, funded clinical trials related to tissue repair.
As of 2013-2014, OREF contributed US$ 150,000 - US$ 225,000 (US$ 75,000 per year) to research initiatives in the U.S. The objective of this funding is to support researchers conducting collaborative efforts that are primarily focused on the study, development, and growth of new cell and tissue-based techniques to prevent tissue damage, enable repair and regeneration, or to substitute injured or damaged tissues.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Biomimetic-synthetic-Absorbable Dural Graft Gaining Traction among Medical Professionals
Rising need for grafts with minimal side-effects, and additional functionality by neurosurgeons in hospitals, ambulatory surgical centers, and trauma centers, are increasing dural graft product adoption among medical professionals.
Post-operative complications, including immunological reaction and infections, are the major challenges associated with classical dural grafts, which is expected to hamper the growth of the dural graft market.
Neurosurgeons prefer dural grafts that are structurally similar to natural dura mater, bioabsorbable, nanostructured synthetic focusing on low cost alternative and patient comfort.
Recently, in 2015, a Chinese dural graft manufacturer - Medprine - launched an innovative biomimetic-synthetic-absorbable next generation dural graft known as ReDura®, manufactured by advanced 3D bio-printing technology. Currently ReDura® is marketed across more than 50 countries around the world.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
An extensive analysis of the dural graft market has brought our analysts to a conclusion that, the market is growing at a significant pace. Currently, xenogeneic dural grafts and synthetic dural grafts are the almost equally targeted segments by major players. Hence, these segments dominate the global dural graft market by product type in term of revenue. North America and Europe collectively hold more than 55% revenue share of the global dural graft market, owing to the high adoption of dural graft-based neurosurgical procedures in these region. Developing countries such as Brazil, India, and South Africa are expected to offer lucrative opportunities for the dural graft market, owing to increasing healthcare expenditure and healthcare infrastructure reforms of specialized hospitals and clinics.
Key Segments of Dural Graft Market
PMR’s study on the dural graft market offers information divided into five important segments - product type, application, material, end user, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.
Key Questions Answered in PMR’s Dural Graft Market Report
- Which regions will continue to remain the most profitable regional markets for dural graft market players?
- Which factors will induce a change in the demand for dural graft during the assessment period?
- How will changing trends impact the dural graft market?
- How can market players capture the low-hanging opportunities in the dural graft market in developed regions?
- What are the winning strategies of stakeholders in the dural graft market to upscale their position in this landscape?
- What are the restraints that investors need to be aware of and tackle while investing in the dural graft market?
- What are the developmental trends in dural graft sectors that will impact the market?
- How can businesses in the dural graft market avail growth opportunities in developed and emerging economies?